Apelin receptor (apj) agonists and uses thereof
AssigneeResearch Triangle Institute
InventorsScott P. RUNYON, Rangan MAITRA, Sanju NARAYANAN, James Barnwell THOMAS
Life of this patent
Estimating the term…
Abstract
This disclosure is directed to agonists of the apelin receptor (APJ) and uses of such agonists.
Claims30
-29 (canceled)
A compound represented by the Formula I:
- or a pharmaceutically acceptable salt, a prodrug, or a salt of a prodrug,
- wherein
- R1 is represented by the formula:
- each A is independently C1-8 alkyl, C1-8 alkyl(aryl), C1-8 alkoxy, C1-8 alkoxy aryl, C2-8 alkenyl, C3-8 alkynyl, C3-8 cycloalkyl, —CF3, —(CH2)x(NR7R8, —CN, —CONR7R8, —COR7, —CO2(CH2)xNR7R8, —CO2R7, halogen, hydroxyl, —N3, —NHCOR7, —NHSO2C1-8 alkyl, —NHCO2C1-8 alkyl, —NO2, —NR7R8, —O(CH2)x(NR7R8, —O(CH2)xCO2R7, —OCOC1-8 alkyl, —OCO(CH2)xNR7R8, —SO(1-3)R7, or —SR7;
- R7 and R8 are independently alkoxy, aryl, C1-8 alkyl, C1-8 alkyl alcohol, C1-8 alkyl amino, C1-8 alkyl amido, C1-8 alkyl(aryl), C1-8 alkyl (C3-8 cycloalkyl), C1-8 alkyl guanidinyl, C1-8 alkyl heteroaryl, C1-8 alkyl imidazolyl, C1-8 alkyl indolyl, C1-8 alkyl thioether, C1-8 alkyl thiol, C2-8 alkenyl, C3-8 alkynyl, C3-8 cycloalkyl, —(CH2)xCONHR9, —(CH2)xCOR9, —(CH2)xCO2R9, H, or heteroaryl;
- or R7 and R8 together make a 3-8 member ring which may be substituted with one or more heteroatoms;
- n is 1, 2, 3, 4 or 5;
- each x is independently 0-8;
- R2 is present or absent, and if present, is substituted aryl, C1-8 alkyl, C1-8 alkyl (C3-8 cycloalkyl), C3-8 cycloalkyl, or heteroaryl;
- R3 is present or absent, is absent if R2 is present, and if present is aryl, C1-8 alkyl, C1-8 alkyl(aryl), C1-8 alkyl (C3-8 cycloalkyl), or C3-8 cycloalkyl;
- R4, R5, and R6 are independently adamantanyl, aryl, C1-8 alkyl, C1-8 alkyl alcohol, C1-8 alkyl amino, C1-8 alkyl amido, C1-8 alkyl(aryl), C1-8 alkyl (C3-8 cycloalkyl), C1-8 alkyl (C3-8 cycloalkyl)-CO2R7, C1-8 alkyl guanidinyl, C1-8 alkyl heteroaryl, C1-8 alkyl imidazolyl, C1-8 alkyl indolyl, C1-8 alkyl thioether, C1-8 alkyl thiol, C2-8 alkenyl, C3-8 alkynyl, C3-8 cycloalkyl, C3-8 cycloalkyl-CO2R7, —(CH2)xNR7R8, —(CH2)xOR7, —(CH2)xNHCOR7, —(CH2)xNHCO2R7, —(CH2)xCONR7R8, —(CH2)xCONR7(CH2)yCO2R9, —(CH2)xCONR7(CH2)yCONR7R8, —(CH2)xCONR7(CH2)yR9, —(CH2)xCOR7, —(CH2)xCO2R7, —CHR7COR9, —CHR7CONHCHR8COR9, —CONR7R8, —CONR7(CH2)xCO2R8, —CONR7CHR8CO2R9, —CO2R9, H, or —NHCO2R7;
- or R4 and R5 together make a 4-8 member ring which may be substituted with one or more heteroatoms or selected from the groups comprising R6;
- R9 is aryl, C1-8 alkoxy, C1-8 alkyl, C1-8 alkyl(aryl), C3-8 cycloalkyl, H, heteroaryl, or hydroxyl;
- each y is independently 1-8;
- and Z is H2 or ═O.
The compound of claim 1 having the structure of any of compounds 34, 34P, 56, 65, 67, 70, 71, 77, 79, 81, 82, 86, 93, 95, 103, 118, 126, 127, 129, 130, 132, 133, 134, 136, 137, 138, 140, 141, 142, 143, 153, 154, 155, 156, 157, 161, 162, 163, 164, 167, 168, 169, 171, 172, 173, 174, 175, 176, 181, 182, 183, 184, 185, 186, 187, 188, 189, 191, 198, 204, 205, 212, 213, 214, 215, 217, 218, 219, 220, 225, 226, 228, 229, 231, 232, 233, 234, 235, 236, 238, 239, 240, 241, 242, 245, 247, 249, 251, 252, 253, 256, 257, 258, 259, 263, and 265, as set forth in Table 1.
Dependencies are inferred from the claim text.